| Primary |
| Antiretroviral Therapy |
42.9% |
| Cerebral Toxoplasmosis |
28.6% |
| Drug Use For Unknown Indication |
14.3% |
| Hiv Infection |
14.3% |
|
| Genotype Drug Resistance Test Positive |
50.0% |
| Immune Reconstitution Syndrome |
50.0% |
|
| Secondary |
| Hiv Infection |
77.5% |
| Antiretroviral Therapy |
10.1% |
| Drug Use For Unknown Indication |
4.7% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Prophylaxis |
0.8% |
| Hiv Test Positive |
0.8% |
| Human Immunodeficiency Virus Transmission |
0.7% |
| Antiviral Prophylaxis |
0.6% |
| Tuberculosis |
0.6% |
| Drug Exposure During Pregnancy |
0.3% |
| Product Used For Unknown Indication |
0.3% |
| Pain |
0.3% |
| Foetal Exposure During Pregnancy |
0.2% |
| Renal Transplant |
0.2% |
| Diffuse Large B-cell Lymphoma |
0.2% |
| Lymph Node Tuberculosis |
0.2% |
| Antifungal Prophylaxis |
0.1% |
| Asthma |
0.1% |
| Glomerulonephritis |
0.1% |
|
| Progressive External Ophthalmoplegia |
21.9% |
| Portal Hypertension |
12.7% |
| Pregnancy |
8.9% |
| Varices Oesophageal |
6.8% |
| Nephropathy Toxic |
5.5% |
| Splenomegaly |
4.6% |
| Pulmonary Hypertension |
4.2% |
| Treatment Failure |
4.2% |
| Premature Baby |
3.8% |
| Immune Reconstitution Syndrome |
3.4% |
| Vomiting |
3.4% |
| Intra-uterine Death |
3.0% |
| Arteriosclerosis |
2.5% |
| Nodular Regenerative Hyperplasia |
2.5% |
| Drug Resistance |
2.1% |
| Lipodystrophy Acquired |
2.1% |
| Ophthalmoplegia |
2.1% |
| Trisomy 21 |
2.1% |
| Virologic Failure |
2.1% |
| Weight Decreased |
2.1% |
|
| Concomitant |
| Hiv Infection |
67.9% |
| Antiretroviral Therapy |
6.5% |
| Drug Use For Unknown Indication |
5.1% |
| Tuberculosis |
3.2% |
| Burkitt's Lymphoma |
2.6% |
| Opportunistic Infection Prophylaxis |
1.6% |
| Systemic Antiviral Treatment |
1.6% |
| Product Used For Unknown Indication |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.4% |
| Hypertension |
1.2% |
| Renal Transplant |
1.1% |
| Non-hodgkin's Lymphoma Stage Iv |
1.0% |
| Ascites |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Diarrhoea |
0.7% |
| Febrile Neutropenia |
0.7% |
| Hepatitis C |
0.7% |
| Sinusitis |
0.7% |
| Coronary Artery Disease |
0.5% |
| Isosporiasis |
0.5% |
|
| Abortion Spontaneous |
8.8% |
| Renal Failure |
8.8% |
| Vomiting |
8.8% |
| Paralysis |
6.3% |
| Renal Tubular Necrosis |
6.3% |
| Weight Decreased |
6.3% |
| Hodgkin's Disease |
5.0% |
| Osteoporosis |
5.0% |
| Rhabdomyolysis |
5.0% |
| Acute Myocardial Infarction |
3.8% |
| Cushing's Syndrome |
3.8% |
| Neutropenia |
3.8% |
| Oesophageal Candidiasis |
3.8% |
| Pancreatitis Acute |
3.8% |
| Pathological Fracture |
3.8% |
| Pelvic Fracture |
3.8% |
| Renal Failure Acute |
3.8% |
| Serotonin Syndrome |
3.8% |
| Thoracic Vertebral Fracture |
3.8% |
| Abdominal Mass |
2.5% |
|
| Interacting |
| Hiv Infection |
38.2% |
| Hodgkin's Disease |
11.8% |
| Unrelated Donor Bone Marrow Transplantation Therapy |
11.8% |
| Fungal Infection |
8.8% |
| Antifungal Prophylaxis |
5.9% |
| Antiretroviral Therapy |
5.9% |
| Antiviral Prophylaxis |
5.9% |
| Antibiotic Prophylaxis |
2.9% |
| Contraception |
2.9% |
| Graft Versus Host Disease |
2.9% |
| Hiv Test Positive |
2.9% |
|
| Pregnancy On Contraceptive |
25.0% |
| Renal Impairment |
25.0% |
| Toxicity To Various Agents |
25.0% |
| Transaminases Increased |
25.0% |
|
